Skip to Content

E193 E193 (Zonisamide 25 mg)

Pill with imprint E193 E193 is Orange / Gray, Capsule-shape and has been identified as Zonisamide 25 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Zonisamide is used in the treatment of migraine prevention; seizures; parkinsonian tremor; benign essential tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy. Zonisamide 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for E193 E193

Zonisamide

Imprint:
E193 E193
Strength:
25 mg
Color:
Orange / Gray
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
microcrystalline cellulose
ferrosoferric oxide
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
hydrogenated castor oil
sodium lauryl sulfate
titanium dioxide
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide